Coloplast A/S (OTCMKTS:CLPBY) Reaches New 52-Week Low – Here’s What Happened

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY)’s stock price reached a new 52-week low on Monday . The stock traded as low as $5.86 and last traded at $5.93, with a volume of 3026 shares trading hands. The stock had previously closed at $6.00.

Analyst Upgrades and Downgrades

CLPBY has been the topic of several recent research reports. Kepler Capital Markets raised shares of Coloplast A/S to a “strong-buy” rating in a report on Wednesday, May 20th. The Goldman Sachs Group cut shares of Coloplast A/S from a “hold” rating to a “strong sell” rating in a research note on Tuesday, April 7th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Coloplast A/S currently has an average rating of “Hold”.

Coloplast A/S Stock Down 0.7%

The firm’s 50 day moving average is $6.46 and its 200-day moving average is $7.59. The firm has a market cap of $13.43 billion, a PE ratio of 42.57, a P/E/G ratio of 1.90 and a beta of 0.18. The company has a quick ratio of 0.81, a current ratio of 1.30 and a debt-to-equity ratio of 1.50.

Coloplast A/S (OTCMKTS:CLPBY) last released its earnings results on Tuesday, May 12th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.09 by $0.01. The firm had revenue of $1.11 billion during the quarter, compared to analysts’ expectations of $1.11 billion. Coloplast A/S had a net margin of 7.46% and a return on equity of 31.96%. As a group, equities research analysts expect that Coloplast A/S Sponsored ADR will post 0.4 earnings per share for the current fiscal year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.